{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:10:24Z","timestamp":1779340224358,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":33,"publisher":"Springer US","isbn-type":[{"value":"9781071648230","type":"print"},{"value":"9781071648247","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-4824-7_11","type":"book-chapter","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:44:08Z","timestamp":1761547448000},"page":"139-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Novel\u00a0Method to Silence Genes in Cryptosporidium"],"prefix":"10.1007","author":[{"given":"Alejandro","family":"Castellanos-Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"4","key":"11_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/MMBR.67.4.657-685.2003","volume":"67","author":"N Agrawal","year":"2003","unstructured":"Agrawal N, Dasaradhi PV, Mohmmed A, Malhotra P, Bhatnagar RK, Mukherjee SK (2003) RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev 67(4):657\u2013685. https:\/\/doi.org\/10.1128\/MMBR.67.4.657-685.2003","journal-title":"Microbiol Mol Biol Rev"},{"issue":"6669","key":"11_CR2","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/35888","volume":"391","author":"A Fire","year":"1998","unstructured":"Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391(6669):806\u2013811. https:\/\/doi.org\/10.1038\/35888","journal-title":"Nature"},{"issue":"9","key":"11_CR3","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.jprot.2011.02.032","volume":"74","author":"TM Batista","year":"2011","unstructured":"Batista TM, Marques JT (2011) RNAi pathways in parasitic protists and worms. J Proteome 74(9):1504\u20131514. https:\/\/doi.org\/10.1016\/j.jprot.2011.02.032","journal-title":"J Proteome"},{"issue":"2","key":"11_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/ph6020124","volume":"6","author":"O Perwitasari","year":"2013","unstructured":"Perwitasari O, Bakre A, Tompkins SM, Tripp RA (2013) siRNA genome screening approaches to therapeutic drug repositioning. Pharmaceuticals (Basel) 6(2):124\u2013160. https:\/\/doi.org\/10.3390\/ph6020124","journal-title":"Pharmaceuticals (Basel)"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-394303-3.00002-5","volume":"78","author":"R Manzano-Roman","year":"2012","unstructured":"Manzano-Roman R, Oleaga A, Perez-Sanchez R, Siles-Lucas M (2012) Gene silencing in parasites: current status and future prospects. Adv Parasitol 78:1\u201355. https:\/\/doi.org\/10.1016\/B978-0-12-394303-3.00002-5","journal-title":"Adv Parasitol"},{"key":"11_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1112755","volume":"11","author":"R Fopase","year":"2023","unstructured":"Fopase R, Panda C, Rajendran AP, Uludag H, Pandey LM (2023) Potential of siRNA in COVID-19 therapy: emphasis on in silico design and nanoparticles based delivery. Front Bioeng Biotechnol 11:1112755. https:\/\/doi.org\/10.3389\/fbioe.2023.1112755","journal-title":"Front Bioeng Biotechnol"},{"issue":"4","key":"11_CR7","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202115298","volume":"14","author":"YC Chang","year":"2022","unstructured":"Chang YC, Yang CF, Chen YF, Yang CC, Chou YL, Chou HW, Chang TY, Chao TL, Hsu SC, Ieong SM, Tsai YM, Liu PC, Chin YF, Fang JT, Kao HC, Lu HY, Chang JY, Weng RS, Tu QW, Chang FY, Huang KY, Lee TY, Chang SY, Yang PC (2022) A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant. EMBO Mol Med 14(4):e15298. https:\/\/doi.org\/10.15252\/emmm.202115298","journal-title":"EMBO Mol Med"},{"issue":"4","key":"11_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nsmb918","volume":"12","author":"FV Rivas","year":"2005","unstructured":"Rivas FV, Tolia NH, Song JJ, Aragon JP, Liu J, Hannon GJ, Joshua-Tor L (2005) Purified Argonaute2 and an siRNA form recombinant human RISC. Nat Struct Mol Biol 12(4):340\u2013349. https:\/\/doi.org\/10.1038\/nsmb918","journal-title":"Nat Struct Mol Biol"},{"issue":"10","key":"11_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001161","volume":"6","author":"LF Lye","year":"2010","unstructured":"Lye LF, Owens K, Shi H, Murta SM, Vieira AC, Turco SJ, Tschudi C, Ullu E, Beverley SM (2010) Retention and loss of RNA interference pathways in trypanosomatid protozoans. PLoS Pathog 6(10):e1001161. https:\/\/doi.org\/10.1371\/journal.ppat.1001161","journal-title":"PLoS Pathog"},{"issue":"7012","key":"11_CR10","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/nature02977","volume":"431","author":"P Xu","year":"2004","unstructured":"Xu P, Widmer G, Wang Y, Ozaki LS, Alves JM, Serrano MG, Puiu D, Manque P, Akiyoshi D, Mackey AJ, Pearson WR, Dear PH, Bankier AT, Peterson DL, Abrahamsen MS, Kapur V, Tzipori S, Buck GA (2004) The genome of Cryptosporidium hominis. Nature 431(7012):1107\u20131112. https:\/\/doi.org\/10.1038\/nature02977","journal-title":"Nature"},{"issue":"5669","key":"11_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1126\/science.1094786","volume":"304","author":"MS Abrahamsen","year":"2004","unstructured":"Abrahamsen MS, Templeton TJ, Enomoto S, Abrahante JE, Zhu G, Lancto CA, Deng M, Liu C, Widmer G, Tzipori S, Buck GA, Xu P, Bankier AT, Dear PH, Konfortov BA, Spriggs HF, Iyer L, Anantharaman V, Aravind L, Kapur V (2004) Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science 304(5669):441\u2013445. https:\/\/doi.org\/10.1126\/science.1094786","journal-title":"Science"},{"issue":"8","key":"11_CR12","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/infdis\/jiv588","volume":"213","author":"A Castellanos-Gonzalez","year":"2016","unstructured":"Castellanos-Gonzalez A, Perry N, Nava S, White AC Jr (2016) Preassembled single-stranded RNA-Argonaute complexes: a novel method to silence genes in Cryptosporidium. J Infect Dis 213(8):1307\u20131314. https:\/\/doi.org\/10.1093\/infdis\/jiv588","journal-title":"J Infect Dis"},{"issue":"5","key":"11_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2012.08.014","volume":"150","author":"WF Lima","year":"2012","unstructured":"Lima WF, Prakash TP, Murray HM, Kinberger GA, Li W, Chappell AE, Li CS, Murray SF, Gaus H, Seth PP, Swayze EE, Crooke ST (2012) Single-stranded siRNAs activate RNAi in animals. Cell 150(5):883\u2013894. https:\/\/doi.org\/10.1016\/j.cell.2012.08.014","journal-title":"Cell"},{"issue":"7","key":"11_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011837","volume":"5","author":"WC Chiang","year":"2010","unstructured":"Chiang WC, Geel TM, Altintas MM, Sever S, Ruiters MH, Reiser J (2010) Establishment of protein delivery systems targeting podocytes. PLoS One 5(7):e11837. https:\/\/doi.org\/10.1371\/journal.pone.0011837","journal-title":"PLoS One"},{"issue":"1","key":"11_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10616-007-9102-3","volume":"56","author":"CO Weill","year":"2008","unstructured":"Weill CO, Biri S, Adib A, Erbacher P (2008) A practical approach for intracellular protein delivery. Cytotechnology 56(1):41\u201348. https:\/\/doi.org\/10.1007\/s10616-007-9102-3","journal-title":"Cytotechnology"},{"issue":"Web Server issu","key":"11_CR16","doi-asserted-by":"publisher","first-page":"W135","DOI":"10.1093\/nar\/gkh449","volume":"32","author":"Y Ding","year":"2004","unstructured":"Ding Y, Chan CY, Lawrence CE (2004) Sfold web server for statistical folding and rational design of nucleic acids. Nucleic Acids Res 32(Web Server issue):W135\u2013W141. https:\/\/doi.org\/10.1093\/nar\/gkh449","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"11_CR17","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nmeth780","volume":"2","author":"G Schramm","year":"2005","unstructured":"Schramm G, Ramey R (2005) siRNA design including secondary structure target site prediction. Nat Methods 2(8):632\u2013632. https:\/\/doi.org\/10.1038\/nmeth780","journal-title":"Nat Methods"},{"issue":"1","key":"11_CR18","doi-asserted-by":"publisher","first-page":"12153","DOI":"10.1038\/s41598-019-48544-z","volume":"9","author":"A Castellanos-Gonzalez","year":"2019","unstructured":"Castellanos-Gonzalez A, Martinez-Traverso G, Fishbeck K, Nava S, White AC Jr (2019) Systematic gene silencing identified Cryptosporidium nucleoside diphosphate kinase and other molecules as targets for suppression of parasite proliferation in human intestinal cells. Sci Rep 9(1):12153. https:\/\/doi.org\/10.1038\/s41598-019-48544-z","journal-title":"Sci Rep"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/2277-9175.98152","volume":"1","author":"N Nayerossadat","year":"2012","unstructured":"Nayerossadat N, Maedeh T, Ali PA (2012) Viral and nonviral delivery systems for gene delivery. Adv Biomed Res 1:27. https:\/\/doi.org\/10.4103\/2277-9175.98152","journal-title":"Adv Biomed Res"},{"key":"11_CR20","doi-asserted-by":"publisher","unstructured":"Nava S, White AC Jr, Castellanos-Gonzalez A (2019) Cryptosporidium parvum subtilisin-like serine protease (SUB1) is crucial for parasite egress from host cells. Infect Immun 87(5). https:\/\/doi.org\/10.1128\/IAI.00784-18","DOI":"10.1128\/IAI.00784-18"},{"key":"11_CR21","doi-asserted-by":"publisher","unstructured":"Castellanos-Gonzalez A, Sadiqova A, Ortega-Mendez J, White AC Jr (2022) RNA-based therapy for Cryptosporidium parvum infection: proof-of-concept studies. Infect Immun:e0019622. https:\/\/doi.org\/10.1128\/iai.00196-22","DOI":"10.1128\/iai.00196-22"},{"issue":"12","key":"11_CR22","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/infdis\/jiw481","volume":"214","author":"A Castellanos-Gonzalez","year":"2016","unstructured":"Castellanos-Gonzalez A, Sparks H, Nava S, Huang W, Zhang Z, Rivas K, Hulverson MA, Barrett LK, Ojo KK, Fan E, Van Voorhis WC, White AC Jr (2016) A novel calcium-dependent kinase inhibitor, bumped kinase inhibitor 1517, cures cryptosporidiosis in immunosuppressed mice. J Infect Dis 214(12):1850\u20131855. https:\/\/doi.org\/10.1093\/infdis\/jiw481","journal-title":"J Infect Dis"},{"issue":"3","key":"11_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1574-6968.1994.tb07045.x","volume":"120","author":"M Tilley","year":"1994","unstructured":"Tilley M, Upton SJ (1994) Both cp15 and cp25 are left as trails behind gliding sporozoites of cryptosporidium parvum (apicomplexa). FEMS Microbiol Lett 120(3):275\u2013278","journal-title":"FEMS Microbiol Lett"},{"key":"11_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2020.111277","volume":"237","author":"S Nava","year":"2020","unstructured":"Nava S, Sadiqova A, Castellanos-Gonzalez A, White AC Jr (2020) Cryptosporidium parvum cyclic GMP-dependent protein kinase (PKG): an essential mediator of merozoite egress. Mol Biochem Parasitol 237:111277. https:\/\/doi.org\/10.1016\/j.molbiopara.2020.111277","journal-title":"Mol Biochem Parasitol"},{"issue":"42","key":"11_CR25","doi-asserted-by":"publisher","first-page":"10750","DOI":"10.1073\/pnas.1810137115","volume":"115","author":"J Janes","year":"2018","unstructured":"Janes J, Young ME, Chen E, Rogers NH, Burgstaller-Muehlbacher S, Hughes LD, Love MS, Hull MV, Kuhen KL, Woods AK, Joseph SB, Petrassi HM, McNamara CW, Tremblay MS, Su AI, Schultz PG, Chatterjee AK (2018) The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis. Proc Natl Acad Sci USA 115(42):10750\u201310755. https:\/\/doi.org\/10.1073\/pnas.1810137115","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"11_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/14787210.2018.1500457","volume":"16","author":"MA Chavez","year":"2018","unstructured":"Chavez MA, White AC Jr (2018) Novel treatment strategies and drugs in development for cryptosporidiosis. Expert Rev Anti-Infect Ther 16(8):655\u2013661. https:\/\/doi.org\/10.1080\/14787210.2018.1500457","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"9","key":"11_CR27","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/14728222.2020.1785432","volume":"24","author":"B Wang","year":"2020","unstructured":"Wang B, Castellanos-Gonzalez A, White AC Jr (2020) Novel drug targets for treatment of cryptosporidiosis. Expert Opin Ther Targets 24(9):915\u2013922. https:\/\/doi.org\/10.1080\/14728222.2020.1785432","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"11_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/cid\/ciaa421","volume":"73","author":"P Iroh Tam","year":"2021","unstructured":"Iroh Tam P, Arnold SLM, Barrett LK, Chen CR, Conrad TM, Douglas E, Gordon MA, Hebert D, Henrion M, Hermann D, Hollingsworth B, Houpt E, Jere KC, Lindblad R, Love MS, Makhaza L, McNamara CW, Nedi W, Nyirenda J, Operario DJ, Phulusa J, Quinnan GV, Sawyer LA, Thole H, Toto N, Winter A, Van Voorhis WC (2021) Clofazimine for treatment of cryptosporidiosis in human immunodeficiency virus infected adults: an experimental medicine, randomized, double-blind, placebo-controlled phase 2a trial. Clin Infect Dis 73(2):183\u2013191. https:\/\/doi.org\/10.1093\/cid\/ciaa421","journal-title":"Clin Infect Dis"},{"issue":"6","key":"11_CR29","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1021\/acs.molpharmaceut.0c01239","volume":"18","author":"MI Sajid","year":"2021","unstructured":"Sajid MI, Moazzam M, Cho Y, Kato S, Xu A, Way JJ, Lohan S, Tiwari RK (2021) siRNA therapeutics for the therapy of COVID-19 and other coronaviruses. Mol Pharm 18(6):2105\u20132121. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c01239","journal-title":"Mol Pharm"},{"issue":"1","key":"11_CR30","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/s41598-018-20632-6","volume":"8","author":"RL Ball","year":"2018","unstructured":"Ball RL, Bajaj P, Whitehead KA (2018) Oral delivery of siRNA lipid nanoparticles: fate in the gi tract. Sci Rep 8(1):2178. https:\/\/doi.org\/10.1038\/s41598-018-20632-6","journal-title":"Sci Rep"},{"issue":"9","key":"11_CR31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrg3978","volume":"16","author":"A Wittrup","year":"2015","unstructured":"Wittrup A, Lieberman J (2015) Knocking down disease: a progress report on siRNA therapeutics. Nat Rev Genet 16(9):543\u2013552. https:\/\/doi.org\/10.1038\/nrg3978","journal-title":"Nat Rev Genet"},{"key":"11_CR32","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.3389\/fmicb.2018.02151","volume":"9","author":"A Levanova","year":"2018","unstructured":"Levanova A, Poranen MM (2018) RNA interference as a prospective tool for the control of human viral infections. Front Microbiol 9:2151. https:\/\/doi.org\/10.3389\/fmicb.2018.02151","journal-title":"Front Microbiol"},{"key":"11_CR33","doi-asserted-by":"publisher","unstructured":"Tashima T (2021) Delivery of orally administered digestible antibodies using nanoparticles. Int J Mol Sci 22(7). https:\/\/doi.org\/10.3390\/ijms22073349","DOI":"10.3390\/ijms22073349"}],"container-title":["Methods in Molecular Biology","Cryptosporidium"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4824-7_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:43:17Z","timestamp":1779338597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4824-7_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"ISBN":["9781071648230","9781071648247"],"references-count":33,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4824-7_11","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"28 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}